Our mission

Giving people with migraine a better life

Reduce brightness?
Turn on Migraine Friendly Mode
Woman in a hilly landscape celebrating life with her hands in the air.
Logo Salvia figurative mark round - diapositive
Salvia Bioelectronics

A bioelectronic solution to restore hope, health and happiness

As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives. Our personalized migraine therapy is tailored to the needs of individual patients. And our ambition does not stop there. With our unique bioelectronic technology, we are also exploring applications for other neurological disorders. Our unwavering commitment is driven by a deep desire to restore hope, health and happiness to people around the globe by improving the overall well-being and quality of life for individuals and their families.

Salvia’s device is not yet approved for commercial use. We make no claims about safety or effectiveness.

Team

Meet our team

Salvia BioElectronics has experienced remarkable growth over the past seven years. We now have 48 colleagues from all over the world, representing more than 12 nationalities. Our home is High Tech Campus Eindhoven, also known as the smartest square kilometer in Europe, where more than 300 high-tech companies are developing the technologies of the future.

Our team
NEWS

Salvia Selected for MedTech Innovator Accelerator 2024

Salvia BioElectronics is one of the companies selected for the MedTech Innovator Accelerator 2024. "We are absolutely thrilled," says Salvia CEO Hubert Martens. "With over 1300 applicants, only the top 5% made it through the rigorous selection process; this is an amazing group to be a part of. We're looking forward to connecting with like-minded entrepreneurs and are excited to have the opportunity to learn from the best in class and get expert support to further detail and pressure test our commercialization plans."

About

It is not “just a headache”

Migraine affects more than one billion people worldwide each year and is the leading cause of disability in people under 50. Cluster headache, which causes excruciating pain behind the eye, is a rare neurological disorder affecting 1 in 1000 people. Read more about both conditions we address with our bioelectronic solution.

Jobs

Join our team

Our team is growing and we are always looking for passionate and talented individuals who want to be part of our mission to give people with migraine a better life.

We also encourage open applications; please submit yours here!

Acquisition is not appreciated.

View all jobs
Logo Salvia figurative mark round - diapositive
Sorry, there are currently no jobs to display.
news & more

Stay informed

Faces of Salvia

Meet Brian, our technician

"I know how an implant can change your life, and I want others to experience the same impact.”

Read post
Faces of Salvia

Meet Steve Gee, our Senior Electronics Engineer

“I design electronics not only out of personal passion, but primarily because I want to make a meaningful impact on people's lives.”

Read post
Press release

Salvia awarded €5.1M funding from European Innovation Council

Today, the European Innovation Council (EIC) announced Salvia was awarded a €5.1M blended funding award from EIC’s accelerator program for the clinical development of a complementary chronic cluster headache indication for its innovative neuromodulation system.

Read post
Meet our investors

Meet our investors

Logo BOM
Logo Dolby Family
Logo Inkef
Logo Panakès
Logo SHS Capital
Logo Thuja
Figure Salvia in white color

Salvia Insights

Later in 2024, we will provide updates on our latest clinical trials and other developments. Stay informed about Salvia's mission?

We value your privacy and will only use your email to send you updates about Salvia BioElectronics. Your information will always remain confidential and will not be shared with third parties. You can unsubscribe at any time.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.